All placebos aren’t created equal: the way they’re delivered can make a difference in how patients respond to the sham therapy, new research has found. A systematic evidence review published in the Annals of Internal Medicine has found that having a clinically significant response to placebo could substantially affect outcomes in placebo-controlled trials. The researchers
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.